These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 13361428)

  • 1. [Results of comparative experimental examinations of the therapeutic effect of antitoxin, formol toxoid and the combination of both on Cl. botulinum-(D)-toxin produced intoxication].
    KATIC RV
    Zentralbl Bakteriol Orig; 1956 Aug; 166(6):510-6. PubMed ID: 13361428
    [No Abstract]   [Full Text] [Related]  

  • 2. A new method for the large-scale production of high-titre botulinum formol-toxoid types C and D.
    STERNE M; WENTZEL LM
    J Immunol; 1950 Aug; 65(2):175-83. PubMed ID: 15436997
    [No Abstract]   [Full Text] [Related]  

  • 3. [THE EFFECT OF PRELIMINARY ADMINISTRATION OF TOXOID ON THE RESISTANCE OF MICE TO BOTULINUM TOXIN. (PRELIMINARY REPORT)].
    ZHUK LN
    Zh Mikrobiol Epidemiol Immunobiol; 1964 Jul; 41():39-42. PubMed ID: 14247222
    [No Abstract]   [Full Text] [Related]  

  • 4. The combination of antitoxin with toxin and toxoid.
    BARR M; GLENNY AT; STEVENS MF
    J Hyg (Lond); 1954 Sep; 52(3):379-96. PubMed ID: 13212041
    [No Abstract]   [Full Text] [Related]  

  • 5. Active and passive protection of mink against type C botulism with type C toxoid and polyvalent antitoxin.
    APPELL RN; HARTSOUGH GR; MCCOY EF; BRANDLY CA
    J Am Vet Med Assoc; 1956 Jun; 128(11):556-8. PubMed ID: 13319190
    [No Abstract]   [Full Text] [Related]  

  • 6. An improved method for development of toxoid vaccines and antitoxins.
    Jones RG; Liu Y; Rigsby P; Sesardic D
    J Immunol Methods; 2008 Aug; 337(1):42-8. PubMed ID: 18571196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PASSIVE IMMUNIZATION.
    OBERMAN JW
    GP; 1964 Sep; 30():131. PubMed ID: 14175950
    [No Abstract]   [Full Text] [Related]  

  • 8. Protective potential of recombinant non-purified botulinum neurotoxin serotypes C and D.
    Moreira C; da Cunha CE; Moreira GM; Mendonça M; Salvarani FM; Moreira ÂN; Conceição FR
    Anaerobe; 2016 Aug; 40():58-62. PubMed ID: 27236078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STUDIES OF THE TOXIN OF CLOSTRIDIUM BOTULINUM. 8. PROCEDURE FOR RAPID DIAGNOSIS OF BOTULINUM INTOXICATION AND ESTABLISHMENT OF THE TYPE OF OFFENDING TOXIN.
    BOROFF DA; FLECK U
    Int Arch Allergy Appl Immunol; 1965; 27():1-5. PubMed ID: 14296892
    [No Abstract]   [Full Text] [Related]  

  • 10. Preparation, measurement and possible use of human antitoxin against Cl. botulinum A, B, and E toxins.
    Habermann E; Bernáth S
    Med Microbiol Immunol; 1975 Jul; 161(3):203-10. PubMed ID: 1237779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of Clostridium botulinum type C antitoxin titers in mink and guinea pigs to protection against type C intoxication in mink.
    Kolbe DR; Coe Clough NE
    Anaerobe; 2008 Apr; 14(2):128-30. PubMed ID: 18032073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory evaluation of a trivalent toxoid for botulism.
    APPLETON GS; WHITE PG
    Am J Vet Res; 1959 Jan; 20():170-2. PubMed ID: 13793982
    [No Abstract]   [Full Text] [Related]  

  • 13. Botulinum antitoxins and antibacterial IgM and IgG antibodies in sera of persons immunized with botulinum polytoxoid combined with cholera vaccine. I. Response to botulinum toxoid.
    Galazka A; Rymkiewicz D; Aleksandrowicz J
    Arch Immunol Ther Exp (Warsz); 1976; 24(5):631-9. PubMed ID: 793566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Field evaluation of Clostridium botulinum type C toxoids in mink.
    APPLETON GS; WHITE PG
    Am J Vet Res; 1959 Jan; 20():166-9. PubMed ID: 13793981
    [No Abstract]   [Full Text] [Related]  

  • 15. Adsorption of type A and B Clostridium botulinum toxoids of varying degrees of purification on aluminium hydroxide.
    VOROB'EV AA; VASIL'EV NN
    Zh Mikrobiol Epidemiol Immunobiol; 1961; 32():1076-81. PubMed ID: 14040100
    [No Abstract]   [Full Text] [Related]  

  • 16. Characterization of new formalin-detoxified botulinum neurotoxin toxoids.
    Keller JE
    Clin Vaccine Immunol; 2008 Sep; 15(9):1374-9. PubMed ID: 18667637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanism of the activation of botulism D toxin by B. licheniformis].
    PREVOT AR; SILLIOC R
    Ann Inst Pasteur (Paris); 1962 Jul; 103():84-7. PubMed ID: 14488696
    [No Abstract]   [Full Text] [Related]  

  • 18. Botulinal toxin and toxoid as antigens.
    Heimach RC; Champion LA; Sugiyama H
    Proc Soc Exp Biol Med; 1970 Oct; 135(1):151-4. PubMed ID: 4920940
    [No Abstract]   [Full Text] [Related]  

  • 19. [Role of water in the etiology of animal botulism. Method of detection of the botulism C toxin in water].
    PIGOURY L; MICHEL C; CHABASSOL C
    Rev Corps Sante Armees Terre Mer Air; 1962 Jun; 3():649. PubMed ID: 14486583
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on immunity to toxins of Clostridium botulinum. VI. Purification and detoxification of type D toxin and the immunological response to toxoid.
    CARDELLA MA; DUFF JT; WINGFIELD BH; GOTTFRIED C
    J Bacteriol; 1960 Mar; 79(3):372-8. PubMed ID: 13807649
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.